Choline-magnesium trisalicylate modulates acute myelogenous leukemia gene expression during induction chemotherapy

Daniel MedinaDivision of Medical Oncology, Rutgers Cancer Institute of New Jersey, Rutgers the State University of New Jersey, NJ, USA;

Kevin DavidDivision of Medical Oncology, Rutgers Cancer Institute of New Jersey, Rutgers the State University of New Jersey, NJ, USA;

Yong LinDepartment of Biostatistics, Rutgers Biomedical and Health Sciences, Piscataway, NJ, USA;

Dale SchaarDivision of Medical Oncology, Rutgers Cancer Institute of New Jersey, Rutgers the State University of New Jersey, NJ, USA;

Vimal PatelDivision of Medical Oncology, Rutgers Cancer Institute of New Jersey, Rutgers the State University of New Jersey, NJ, USA;

Mecide GhariboDivision of Medical Oncology, Rutgers Cancer Institute of New Jersey, Rutgers the State University of New Jersey, NJ, USA;

Rajat BannerjiDivision of Medical Oncology, Rutgers Cancer Institute of New Jersey, Rutgers the State University of New Jersey, NJ, USA;

Kelly WaltonDivision of Medical Oncology, Rutgers Cancer Institute of New Jersey, Rutgers the State University of New Jersey, NJ, USA;

Joseph AisnerDivision of Medical Oncology, Rutgers Cancer Institute of New Jersey, Rutgers the State University of New Jersey, NJ, USA;

Arnold B. RabsonChild Health Institute, Robert Wood Johnson Medical School, Rutgers the State University of New Jersey, NJ, USA

Roger StrairDivision of Medical Oncology, Rutgers Cancer Institute of New Jersey, Rutgers the State University of New Jersey, NJ, USA; Correspondence[email protected]

show all

Click to increase image sizeClick to decrease image size

Acknowledgements

The authors acknowledge support from a Leukemia and Lymphoma Society Translational Research Award. The authors also acknowledge support from the ‘Century for the Cure’ charitable bicycle ride and Two Guys Golf Outing.

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article at http://dx.doi.org/10.1080/10428194.2016.1225206.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Choline-magnesium trisalicylate modulates acute myelogenous leukemia gene expression during induction chemotherapy

Information for

Open access

Opportunities

Help and information

Choline-magnesium trisalicylate modulates acute myelogenous leukemia gene expression during induction chemotherapy

Acknowledgements

Potential conflict of interest

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature